跳至主要内容
临床试验/ISRCTN14330469
ISRCTN14330469进行中(未招募)Unknown

The 6:1 intermittent diet breast cancer prevention programme study

Manchester University NHS Foundation Trust0 个研究点目标入组 30 人开始时间: 2024年5月3日最近更新:
适应症

试验速览

阶段
Unknown
状态
进行中(未招募)
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • •1.Born female and not undergone gender reassignment aged 18-40 years.
  • •2.Moderate or high risk of BC (>17% lifetime risk or >10 year risk of BC of >3% at 40)
  • •3.BMI > or=20 and < or = 25 Kg/m²
  • •4.Able to communicate (written and spoken) in English or other languages
  • •5.Able to attend two face to face appointments at MFT at baseline and 4 months
  • •6.Not pregnant or planning to become pregnant: Where appropriate potential participants will have a negative urine pregnancy test at screening and agreement to maintain contraception or abstinence for the trial.

排除标准

  • •1.Previous breast cancer or bilateral preventative mastectomy
  • •2.Currently trying to gain weight
  • •3.Previously had weight loss surgery or taking weight loss medication
  • •4.Have a medical condition that influences diet and weight, for example, diabetes, inflammatory bowel disease or cystic fibrosis.
  • •5.Current diagnosis of a psychiatric disorder, for example bipolar psychotic disorder or current self-harm
  • •6.Substance abuse or harmful alcohol use as indicated by a score of 16 or above on the Alcohol Use Disorders Identification Test (AUDIT)
  • •7.Current or previous diagnosis of an eating disorder
  • •8.Participants with severe binge eating assessed by a score of 27 or more on the Binge Eating Scale (BES)
  • •9.Participants with severe depression assessed by a score of 15 or more on the Patient Health Questionnaire-9 (PHQ-9) questionnaire
  • •10.Participants with severe anxiety assessed by a score of 15 or more on the General Anxiety Disorder (GAD-7) questionnaire.
  • •11.Confirmed pregnant via a pregnancy test, planning pregnancy in the next 4 months, or currently breast feeding.

研究者

相似试验

已完成
不适用
Breast Risk Reduction Intermittent Diet Evaluation (BRRIDE) studyMalignant neoplasm of breastCancerBreast cancer
ISRCTN77916487niversity Hospital of South Manchester (UHSM) NHS Foundation Trust (UK)25
进行中(未招募)
不适用
Preventing Breast cancer through Assumption of Metformin, Diet and Physical Activity - Bremet Dietwomen affected by metabolic syndrome defined by at least three out of five metabolic factors: 1-glucose >110 mg/100 mL 2-triglycerides >150mg/100mL 3-HDL cholesterol <50 mg/100mL 4-waist circumference >88 cm) 5-hypertension SBP>130 mm Hg or DBP >85 mm HMedDRA version: 9.1Level: SOCClassification code 10038604MedDRA version: 9.1Level: SOCClassification code 10029104MedDRA version: 9.1Level: PTClassification code 10007649MedDRA version: 9.1Level: SOCClassification code 10022891
EUCTR2008-006527-30-ITISTITUTO NAZIONALE PER LA CURA TUMORI
已完成
不适用
Prevention of breast cancer in high risk women by monitoring microrna expression in nipple aspirate fluid.breast carcinoma100836241000629110006232breast cancer
NL-OMON44762niversitair Medisch Centrum Utrecht720
撤回
不适用
A randomised controlled trial of breast cancer patients treated with chemotherapy in a hospital day unit or at home; an analysis of cost and patient reported outcomesCancer - BreastPublic Health - Health service researchBreast cancer
ACTRN12615000197538A/Prof Suzanne Robinson130
已完成
不适用
Dietary approaches for treatment of the metabolic syndrome in overweight and obese women.Metabolic syndrome in overweight and obese womenDiabetes prevention in overweight and obese womenInsulin resistance in overweight and obese womenDiet and Nutrition - ObesityMetabolic and Endocrine - Diabetes
ACTRN12610000852055Professor Jim Mann80
Testing the feasibility of a 6:1 intermittent diet... | 临床试验